ACE and kidney failure: Regarding drug–drug interactions, 2.33% of analyzed prescriptions contained the association of an ACE inhibitor and an ARB for patients with renal failure (identified based on the diagnostic code), followed by the association of AVK and NSAIDs in 0.43% of cases (Table 4).